Sadia L’Baouch

Sadia joined Ixaka in January 2021 with 23 years of manufacturing and supply experience, the majority of those in the pharmaceutical and biotech industries. Most recently at Sangamo Therapeutics where Sadia served as Senior Director Manufacturing and Supply Chain. In this role, Sadia managed the relationship and technical transfer activities with Sangamo’s Contract Manufacturing Organization (CMO) for Clinical Trials Supply. Sadia was also responsible for the set-up of the supply chain for the CARTreg programs, working closely with the clinical teams to ensure provision for clinical supply.

Prior to Sangamo Therapeutics, Sadia spent 17 years at GlaxoSmithKline in the UK, where she held several leadership and management roles in technical support to Commercial Manufacture, she was also Plant Manager for Clinical trials API manufacture, and managed large Clinical supply chains. Sadia spent her last 6 years at GSK as part of the CGT platform. In her last role as Supply Chain Director, Cell & Gene Therapy, she implemented a global supply chain for autologous cell and gene therapy products for Rare Diseases and Oncology and established the supply chain aspects for the launch of Strimvelis. Prior to GSK, Sadia worked in France for nearly 5 years designing and commissioning fertilizer plants worldwide.

Sadia is a senior manufacturing and industry leader who brings with her a substantial level of international business experience and is bilingual French and English.

Sadia holds an MBA from the Warwick Business School, UK and a Master’s in Chemical Engineering (Ingénieur Génie Chimique) from the Université de Technologie de Compiègne (UTC), France. Additionally, Sadia is also a qualified development Coach from the Coaching Academy, London.